A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

Abstract

Among patients at high risk for post-ERCP pancreatitis, rectal indomethacin significantly reduced the incidence of the condition. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT00820612.).